Bell R F, Dahl J B, Moore R A, Kalso E
Haukeland University Hospital/ University of Bergen, Pain Clinic/Dept. of Surgical Sciences, Bergen, Norway, N-5021.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004603. doi: 10.1002/14651858.CD004603.pub2.
Postoperative pain management is often limited by adverse effects such as nausea and vomiting. Adjuvant treatment with an inexpensive opioid-sparing drug such as ketamine may be of value in giving better analgesia with fewer adverse effects.
To evaluate the effectiveness and tolerability of ketamine administered perioperatively in the treatment of acute postoperative pain in adults.
Studies were identified from MEDLINE (1966-2004), EMBASE (1980-2004), the Cochrane Library (2004) and by handsearching reference lists from review articles and trials. The manufacturer of ketamine (Pfizer) provided search results from their in-house database, PARDLARS.
Randomised controlled trials (RCTs) of adult patients undergoing surgery, being treated with perioperative ketamine or placebo. Studies where ketamine was administered in addition to a basic analgesic (such as morphine or NSAID) in one study group, and compared with a group receiving the same basic analgesic (but without ketamine) in another group, were also included.
Two independent reviewers identified fifty five RCTs for potential inclusion. Quality and validity assessment was performed by two independent reviewers. In the case of discrepancy, a third reviewer was consulted. Patient reported pain intensity and pain relief was assessed using visual analogue scales or verbal rating scales and adverse effects data were collated.
Thirty-seven trials were included (2240 participants). Eighteen trials were excluded.Twenty-seven of the 37 trials found that perioperative subanaesthetic doses of ketamine reduced rescue analgesic requirements or pain intensity, or both. Quantitative analysis showed that treatment with ketamine reduced 24 hour PCA morphine consumption and postoperative nausea or vomiting (PONV). Adverse effects were mild or absent.
AUTHORS' CONCLUSIONS: Ketamine in subanaesthetic dose (that is a dose which is below that required to produce anaesthesia) is effective in reducing morphine requirements in the first 24 hours after surgery. Ketamine also reduces postoperative nausea and vomiting. Adverse effects are mild or absent.
术后疼痛管理常受恶心和呕吐等不良反应的限制。使用氯胺酮这种廉价的阿片类药物节省剂进行辅助治疗,可能有助于在减少不良反应的情况下提供更好的镇痛效果。
评估围手术期使用氯胺酮治疗成人急性术后疼痛的有效性和耐受性。
从MEDLINE(1966 - 2004年)、EMBASE(1980 - 2004年)、Cochrane图书馆(2004年)以及通过手工检索综述文章和试验的参考文献列表来识别研究。氯胺酮制造商(辉瑞公司)提供了其内部数据库PARDLARS的检索结果。
对接受手术的成年患者进行围手术期氯胺酮或安慰剂治疗的随机对照试验(RCT)。还包括在一个研究组中,氯胺酮与基本镇痛药(如吗啡或非甾体抗炎药)联合使用,并与另一组接受相同基本镇痛药(但不使用氯胺酮)的组进行比较的研究。
两名独立评审员确定了55项可能纳入的RCT。由两名独立评审员进行质量和有效性评估。如有分歧,咨询第三位评审员。使用视觉模拟量表或语言评分量表评估患者报告的疼痛强度和疼痛缓解情况,并整理不良反应数据。
纳入37项试验(2240名参与者)。排除18项试验。37项试验中的27项发现,围手术期亚麻醉剂量的氯胺酮可降低补救性镇痛药的需求或疼痛强度,或两者均降低。定量分析表明,氯胺酮治疗可减少术后24小时PCA吗啡的消耗量以及术后恶心或呕吐(PONV)。不良反应轻微或无。
亚麻醉剂量的氯胺酮(即低于产生麻醉所需剂量)在降低术后24小时内的吗啡需求量方面有效。氯胺酮还可减少术后恶心和呕吐。不良反应轻微或无。